Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
Cipla
Accenture
Harvard Business School
Daiichi Sankyo
Julphar
Baxter
Fuji

Generated: May 23, 2018

DrugPatentWatch Database Preview

DEMSER Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Demser patents expire, and when can generic versions of Demser launch?

Demser is a drug marketed by Aton Pharma Vpna and is included in one NDA.

The generic ingredient in DEMSER is metyrosine. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the metyrosine profile page.
Drug patent expirations by year for DEMSER
Pharmacology for DEMSER
Synonyms for DEMSER
(-)-(S)-2-Amino-3-(4-hydroxyphenyl)-2-methylpropionsaeure
(-)-alpha-Methyl-L-tyrosine
(2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid
(2S)-2-azanyl-3-(4-hydroxyphenyl)-2-methyl-propanoic acid
(S)-|A-Methyltyrosine
(S)-2-(4-Hydroxybenzyl)-2-aminopropanoic Acid
(S)-2-AMINO-2-METHYL-3-(4'-HYDROXYPHENYL)PROPANOIC ACID
(S)-2-AMINO-3-(2-METHYL-4-HYDROXYPHENYL)PROPANOIC ACID
(S)-2-Amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid
(S)-a-Methyl-4-hydroxy phenylalanine, (S)-a-Methyltyrosine (>98%, >98%ee)
(S)-A-METHYLTYROSINE
(S)-ALPHA-METHYL-4-HYDROXYPHENYLALANINE
(S)-alpha-Methyltyrosine
23239-48-7
672-87-7
672M877
a-methyl-L-p-tyrosine
A-METHYL-L-TYR
A-METHYL-L-TYROSINE
A835693
AB02561
AC1L9B0V
AC1Q29EO
AJ-07916
AK164271
alpha-Me-Tyr-OH
Alpha-Methyl-L-P-Tyrosine
ALPHA-METHYL-L-TYR
alpha-Methyl-L-tyrosine
alpha-Methyl-L-tyrosine, >=98% (TLC)
alpha-Methyl-p-tyrosine
alpha-Methyl-para-tyrosine
alpha-methyl-paratyrosine
alpha-Methyltyrosine
AM002123
AM83582
AmbotzHAA5490
AX8022058
BSPBio_003232
C-23996
C07921
CAS-672-87-7
CC-24015
CCG-204895
CHEBI:6912
CHEMBL1200862
CM-2293
CPD000466921
D00762
DB00765
Demser (TN)
DOQ0J0TPF7
DSSTox_CID_3315
DSSTox_GSID_23315
DSSTox_RID_76972
DTXSID6023315
EINECS 211-599-5
EU-0100811
FCH4035313
FT-0622266
GTPL6956
H-(ME)TYR-OH
H-A-ME-TYR-OH
H-ALPHA-ME-L-TYR-OH
HMS3262D03
KBio3_002732
L 588357-0
L-?-Methyltyrosine
L-|A-Methyl-p-tyrosine
L-|A-Methyltyrosine
L-|A-MT
L-2-ME-TYR-OH
L-2-Methyl-3-(4-hydroxy-phenyl)alanine
L-2-METHYL-3-(4-HYDROXYPHENYL)ALANINE
L-588357-0
L-alpha-Methyl-p-tyrosine
L-ALPHA-METHYLROSINE
L-alpha-Methyltyrosine
l-alpha-MT
L-AMPT
L-Metyrosine
L-Tyrosine, a-methyl-
L-Tyrosine, alpha-methyl-, (-)-
L(-)-Metyrosine
Lopac0_000811
LP00811
M 8131
MCULE-5340647798
Methyltyrosine
Metirosin
Metirosina
Metirosina [INN-Spanish]
Metirosine
Metirosine (JAN/INN)
Metirosine [INN]
Metirosinum
Metirosinum [INN-Latin]
METYROSINE
Metyrosine (USP)
Metyrosine [USAN:USP]
Metyrosine, United States Pharmacopeia (USP) Reference Standard
MFCD00064201
MK 781
MK-781
MolPort-001-792-900
MolPort-044-812-316
NCGC00015701-06
NCGC00094144-01
NCGC00094144-03
NCGC00094144-04
NCGC00094144-05
NCGC00094144-06
NCGC00094144-07
NCGC00261496-01
NHTGHBARYWONDQ-JTQLQIEISA-N
SAM001246895
SCHEMBL50398
SPECTRUM2300312
Spectrum3_001846
Tox21_111253
Tox21_111253_1
Tox21_500811
TR-022622
UNII-DOQ0J0TPF7
UNII-X88TTO174Z component NHTGHBARYWONDQ-JTQLQIEISA-N
Z1617901128
ZINC693

US Patents and Regulatory Information for DEMSER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton Pharma Vpna DEMSER metyrosine CAPSULE;ORAL 017871-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
Boehringer Ingelheim
Colorcon
Mallinckrodt
Baxter
Cerilliant
Fish and Richardson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.